About Asimov
Asimov is a synthetic biology company building tools to program living cells, integrating mammalian synthetic biology with computer-aided design to advance the design and manufacture of therapeutics. Its platform combines engineered host cells, a genetic parts library, and cloud-based design software to serve biopharmaceutical customers developing biologics, cell/gene therapies, and RNA medicines. Founded in 2017 by bioengineers from MIT and Boston University, Asimov enables customers to design, simulate, and optimize genetic systems for therapeutic applications.
Company details
Funding
Total raised
$200M
Last stage
Growth
Investors
Founders
Lyem Ningthou
Defense tech robotics researcher → building the data layer for humanoid robotics
LinkedInAlec Nielsen
Alec Nielsen is Founder & CEO of Asimov, which integrates mammalian synthetic biology, computer-aided design, and machine learning to build tools to program living cells.
LinkedInRaja Srinivas
Raja Srinivas founded Asimov in 2017 in Boston, Massachusetts. The company creates tools for programming living cells using synthetic biology, computer-aided design, and machine learning.
Anshul Verma
Previous software engineering at Scale AI, Amazon and ML research at Berkeley. Building a marketplace for robot data.
LinkedInChris Voigt
Professor at MIT; pioneer in genetic logic circuit design and a founding collaborator on the Cello automated genetic circuit design platform.
Doug Densmore
Professor at Boston University; co-developed the Cello platform with Chris Voigt, building foundations for genetic logic circuit design.
What happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.